Cargando…

Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran

BACKGROUND: Kawasaki Disease is an acute and self-limited systemic inflammatory and febrile illness, which is the most common cause of acquired heart disease in children in developed countries. The incidence of KD in Asian countries is high. But, data is not available from the Middle East. So, the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qazizadeh, Zainab, Shahbaznejad, Leila, Navaeifar, Mohammad Reza, Rezai, Mohammad Sadegh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919186/
https://www.ncbi.nlm.nih.gov/pubmed/35295705
http://dx.doi.org/10.3389/fped.2022.834306
_version_ 1784668901087379456
author Qazizadeh, Zainab
Shahbaznejad, Leila
Navaeifar, Mohammad Reza
Rezai, Mohammad Sadegh
author_facet Qazizadeh, Zainab
Shahbaznejad, Leila
Navaeifar, Mohammad Reza
Rezai, Mohammad Sadegh
author_sort Qazizadeh, Zainab
collection PubMed
description BACKGROUND: Kawasaki Disease is an acute and self-limited systemic inflammatory and febrile illness, which is the most common cause of acquired heart disease in children in developed countries. The incidence of KD in Asian countries is high. But, data is not available from the Middle East. So, the aim of this study was to develop an MDS to set up a national registry for KD to estimate the burden of disease in Iran. MATERIALS AND METHODS: This cross-sectional and descriptive study was conducted in 2020. Literature review, data collection from patients medical records, and expert panel approach were used to design this MDS. Data elements with a Content Validity Ratio (CVR) of more than 0.56 were selected as the MDS of the registry. RESULTS: Overall, 99 data elements were recognized. Of which, 51 and 48 data elements were verified and rejected, respectively. Moreover, 17 data elements were added as required by experts. Eventually, 68 data elements were chosen as the MDS of the national KD registry of IRAN; of which, 17 and 51 data elements were classified as administrative and clinical data, respectively. CONCLUSIONS: These precise, integrated, and comprehensive developed data elements and the national KD registry will lead to effective disease management and thus, improve the quality of care and, consequently, improve public health.
format Online
Article
Text
id pubmed-8919186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89191862022-03-15 Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran Qazizadeh, Zainab Shahbaznejad, Leila Navaeifar, Mohammad Reza Rezai, Mohammad Sadegh Front Pediatr Pediatrics BACKGROUND: Kawasaki Disease is an acute and self-limited systemic inflammatory and febrile illness, which is the most common cause of acquired heart disease in children in developed countries. The incidence of KD in Asian countries is high. But, data is not available from the Middle East. So, the aim of this study was to develop an MDS to set up a national registry for KD to estimate the burden of disease in Iran. MATERIALS AND METHODS: This cross-sectional and descriptive study was conducted in 2020. Literature review, data collection from patients medical records, and expert panel approach were used to design this MDS. Data elements with a Content Validity Ratio (CVR) of more than 0.56 were selected as the MDS of the registry. RESULTS: Overall, 99 data elements were recognized. Of which, 51 and 48 data elements were verified and rejected, respectively. Moreover, 17 data elements were added as required by experts. Eventually, 68 data elements were chosen as the MDS of the national KD registry of IRAN; of which, 17 and 51 data elements were classified as administrative and clinical data, respectively. CONCLUSIONS: These precise, integrated, and comprehensive developed data elements and the national KD registry will lead to effective disease management and thus, improve the quality of care and, consequently, improve public health. Frontiers Media S.A. 2022-02-28 /pmc/articles/PMC8919186/ /pubmed/35295705 http://dx.doi.org/10.3389/fped.2022.834306 Text en Copyright © 2022 Qazizadeh, Shahbaznejad, Navaeifar and Rezai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Qazizadeh, Zainab
Shahbaznejad, Leila
Navaeifar, Mohammad Reza
Rezai, Mohammad Sadegh
Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title_full Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title_fullStr Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title_full_unstemmed Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title_short Developing a National Minimum Data Set for Kawasaki Disease Registry in Iran
title_sort developing a national minimum data set for kawasaki disease registry in iran
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919186/
https://www.ncbi.nlm.nih.gov/pubmed/35295705
http://dx.doi.org/10.3389/fped.2022.834306
work_keys_str_mv AT qazizadehzainab developinganationalminimumdatasetforkawasakidiseaseregistryiniran
AT shahbaznejadleila developinganationalminimumdatasetforkawasakidiseaseregistryiniran
AT navaeifarmohammadreza developinganationalminimumdatasetforkawasakidiseaseregistryiniran
AT rezaimohammadsadegh developinganationalminimumdatasetforkawasakidiseaseregistryiniran